Alex Zhavoronkov

Dr. Alex Zhavoronkov is the founder and CEO of Insilico Medicine, a biotechnology company that specializes in using artificial intelligence to accelerate drug discovery and development. Under his leadership, the company has pioneered the use of generative AI in pharmaceuticals, resulting in the creation of numerous potential drug candidates. His vision focuses on integrating advanced technologies to improve healthcare outcomes and the efficiency of scientific research.